Diagnostics Direct has been at the forefront of supporting public health efforts to combat the syphilis epidemic with their flagship product, Syphilis Health Check™, since 2014. It is the first and only FDA 510k cleared and CLIA-waived rapid syphilis test, recognized for its exceptional sensitivity and delivering accurate results in just 10 minutes. Their mission is to enhance STI detection by equipping healthcare professionals with innovative tools for swift and reliable diagnosis.
Early detection and treatment of syphilis is crucial, especially in vulnerable populations such as pregnant women. In 2023, there were over 3,800 cases of congenital syphilis (when a mother passed syphilis to her baby during pregnancy), resulting in over 275 infant or neonatal deaths. Nearly 90% of these newborn syphilis cases could have been prevented with timely testing and treatment. Syphilis Health Check rapid tests enable earlier detection in a single medical visit, ensuring mothers get the treatment they need to prevent syphilis and congenital syphilis.
Join Jeff Tobias, co-founder of Diagnostics Direct, and Dr. Jeffrey Klausner, one of the nation’s leading infectious disease experts, as they share critical information about the effectiveness of rapid testing and treatment using Syphilis Health Check.
